Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma A/S (ZLDPF) Analyst/Investor Day Transcript
Zealand Pharma A/S (ZLDPF) Analyst/Investor Day December 11, 2025 8:00 AM EST Adam Steensberg - President & CEO Eric Cox - Executive VP & Chief Commercial Officer David Kendall - Executive VP, Chief Medical Officer & Head of R&D Utpal Singh - Chief…
Sun Pharma, MOMS launch eye health campaign
The initiative forms part of Sun Pharma's ongoing #SeeBeyondSugar campaign, which focuses on a holistic approach to diabetes management by encouraging patients and caregivers to look beyond blood sugar control and prioritise long-term quality of…
Corona Remedies IPO: Pharma firm's shares make remarkable market debut with 35% rise, mcap reaches Rs...
Corona Remedies IPO: Shares of pharma firm Corona Remedies Ltd closed with a premium of over 35 per cent against the issue price of Rs 1,062 per share on Monday. The stock started trading at Rs 1,452, a jump of 36.72 per cent from the issue price…
Astellas Pharma (OTCMKTS:ALPMY) Shares Gap Up - Here's What Happened
Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) shares gapped up before the market opened on Monday. The stock had previously closed at $13.08, but opened at $13.92. Astellas Pharma shares last traded at $13.50, with a volume of 247,274…
BridgeBio Pharma (NASDAQ:BBIO) Hits New 12-Month High - Time to Buy?
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) shares reached a new 52-week high during trading on Monday. The stock traded as high as $75.61 and last traded at $74.8140, with a volume of 406545 shares traded. The stock had previously…
BridgeBio Pharma (NASDAQ:BBIO) Stock Price Expected to Rise, Leerink Partners Analyst Says
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its target price upped by Leerink Partners from $75.00 to $86.00 in a report issued on Monday, Benzinga reports. The firm currently has an 'outperform' rating on the stock. Leerink Partners'…
Chinese biotech Scizeng's global licensing deal to yield up to US$1.44 billion
A Chinese biopharmaceutical firm has sealed a global licensing deal valued at up to US$1.44 billion, the second in a week, as a wave of cross-border tie-ups shows no sign of abating despite headwinds from the US Biosecure Act. Shanghai Scizeng…
DPI is the 'hot acronym' in PE right now, says West Monroe; Mérieux Equity Partners to sell pharma commercialization biz to SK Capital
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
Hikma chief executive replaced by former boss after share price weakens
News from The City, market updates plus comment and analysis from our business desk I would like to be emailed about offers, event and updates from Evening Standard. Read our privacy notice. The boss of drugmaker Hikma will be replaced by the…
This Startup Backed By OpenAI and Jobs Family Is the Latest A.I. Drug Discovery Unicorn
Chai Discovery, a San Francisco-based startup backed by OpenAI, is the latest drug discovery company to benefit from a flurry of investments at the intersection of health care and A.I. In its latest funding round, the company raised $130 million to…
Hikma chief executive replaced by former boss after share price weakens
The boss of drugmaker Hikma will be replaced by the firm's former chief executive, the company has announced, after a sharp drop in its share price this year. Riad Mishlawi is stepping down from the top role by “mutual agreement” with…
Jim Cramer's top 10 things to watch in the stock market Monday
My top 10 things to watch Monday Dec. 15 1. The S & P 500 was headed for a higher open as Wall Street awaits key economic data this week. The November employment report and October retail sales numbers will be released on Tuesday morning. On…
Marjorie Taylor Greene Engaged: Former MAGA Queen Set to Marry Brian Glenn as She Gushes Over Her 'Happily Ever After!
Marjorie Taylor Greene is engaged to right-wing journalist Brian Glenn after nearly two years of dating, RadarOnline.com can confirm. Glenn, 56, who serves as the Chief White House Correspondent for Real America's Voice, shared a photo of the newly…
Progressive bid tests Democratic unity in Colorado's First District
Denver progressives see an opportunity to defeat Rep. Diana DeGette, D-Colo., in the Democratic primary in Colorado's first district, with local and national groups gathering behind challenger Melat Kiros in a primary that's shaping up to be as…
Sanofi: Today's Tolebrutinib Setback Shouldn't Worry Shareholders - This Is Why (SNY)
Sanofi faces a setback as tolebrutinib fails its Phase 3 PPMS trial, halting regulatory pursuit for this indication. Meanwhile, an approval decision on the candidate has also been delayed. SNY's growth remains robust, with Q3 sales up 7% YoY, net…
Receive a Daily briefing on Pharma Industry News
Get Started